IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 256 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $3,347,000 | -2.4% | 201,038 | +11.9% | 0.00% | 0.0% |
| Q4 2021 | $3,430,000 | -73.8% | 179,666 | -66.2% | 0.00% | -71.4% |
| Q3 2021 | $13,089,000 | +88.4% | 530,781 | +98.8% | 0.01% | +75.0% |
| Q2 2021 | $6,947,000 | +16.1% | 266,999 | +41.2% | 0.00% | +33.3% |
| Q1 2021 | $5,985,000 | +2.0% | 189,034 | +49.5% | 0.00% | -25.0% |
| Q4 2020 | $5,866,000 | +60.6% | 126,416 | +13.9% | 0.00% | +33.3% |
| Q3 2020 | $3,653,000 | -10.7% | 110,965 | -25.5% | 0.00% | 0.0% |
| Q2 2020 | $4,090,000 | +22.0% | 149,016 | +33.0% | 0.00% | 0.0% |
| Q1 2020 | $3,353,000 | +38.6% | 112,003 | +28.1% | 0.00% | +50.0% |
| Q4 2019 | $2,420,000 | +53.7% | 87,417 | +1.0% | 0.00% | +100.0% |
| Q3 2019 | $1,575,000 | -25.6% | 86,557 | +0.3% | 0.00% | -50.0% |
| Q2 2019 | $2,117,000 | +917.8% | 86,318 | +293.9% | 0.00% | – |
| Q1 2019 | $208,000 | +5.1% | 21,913 | -2.1% | 0.00% | – |
| Q4 2018 | $198,000 | -3.9% | 22,391 | +22.1% | 0.00% | – |
| Q3 2018 | $206,000 | +0.5% | 18,337 | +14.3% | 0.00% | – |
| Q2 2018 | $205,000 | -88.2% | 16,043 | -84.4% | 0.00% | -100.0% |
| Q1 2018 | $1,735,000 | +1214.4% | 102,638 | +521.0% | 0.00% | – |
| Q4 2017 | $132,000 | +3.1% | 16,527 | +0.3% | 0.00% | – |
| Q3 2017 | $128,000 | +2.4% | 16,478 | -3.2% | 0.00% | – |
| Q2 2017 | $125,000 | – | 17,022 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 12,201,261 | $203,150,000 | 4.07% |
| Paradigm Biocapital Advisors LP | 907,428 | $15,109,000 | 4.00% |
| Avoro Capital Advisors LLC | 9,125,000 | $151,931,000 | 2.77% |
| Logos Global Management LP | 1,000,000 | $16,650,000 | 2.16% |
| Avidity Partners Management LP | 6,043,219 | $100,620,000 | 2.10% |
| Orbimed Advisors | 6,633,006 | $110,440,000 | 1.79% |
| Parametrica Management Ltd | 134,679 | $2,240,000 | 1.66% |
| Boxer Capital, LLC | 1,935,133 | $32,220,000 | 1.66% |
| Fairmount Funds Management LLC | 389,588 | $6,487,000 | 1.53% |
| Long Focus Capital Management, LLC | 705,000 | $11,738,000 | 1.51% |